The Tricuspid Valve: A Review of Pathology, Imaging, and Current Treatment Options: A Scientific Statement From the American Heart Association

Laura Davidson(American College of Cardiology), George Dangas(Mount Sinai Hospital), Tiberio Frisoli, Edwin Ho(Montefiore Medical Center), Marat Fudim(Clinical Research Institute), Gilbert H.L. Tang(Mount Sinai Health System), Margaret Bowers, Anton Camaj(Columbia University Irving Medical Center), Jason C. Kovacic(Victor Chang Cardiac Research Institute), Joanna Chikwe(Cedars-Sinai Medical Center), Pavan Atluri(University of Pennsylvania), Peter J. Mason, Sofia Carolina Masri
Circulation
April 25, 2024
10.1161/cir.0000000000001232
Cited by 65

Related Papers

Telehealth transformation: COVID-19 and the rise of virtual care
|Journal of the American Medical Informatics Association|2020|1.6k
Effect of renal denervation on blood pressure in the presence of antihypertensive drugs: 6-month efficacy and safety results from the SPYRAL HTN-ON MED proof-of-concept randomised trial
|The Lancet|2018|781
Catheter-based renal denervation in patients with uncontrolled hypertension in the absence of antihypertensive medications (SPYRAL HTN-OFF MED): a randomised, sham-controlled, proof-of-concept trial
|The Lancet|2017|739
Impact of Oxidative Stress on the Heart and Vasculature
|Journal of the American College of Cardiology|2017|603
Endothelial to Mesenchymal Transition in Cardiovascular Disease
|Journal of the American College of Cardiology|2019|599